Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical Significance of Expression and Amplification of the DcR3 Gene in Pancreatic Carcinomas

(2012) Jian Zhou et al.   Asian Pacific Journal of Cancer Prevention

Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy

(2010) Tomohiro Morishige et al.   BIOMATERIALS

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Dcr3 inhibit p53-dependent apoptosis in γ-irradiated lung cancer cells

(2010) Hye Youn Sung et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients

(2010) Meisongzhu Yang et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Douglas B. Evans et al.   ANNALS OF SURGICAL ONCOLOGY

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

(2009) Mark P. Callery et al.   ANNALS OF SURGICAL ONCOLOGY

Comparison of CT and MRI for presurgical characterization of paraaortic lymph nodes in patients with pancreatico-biliary carcinoma

(2008) Young Chul Kim et al.   WORLD JOURNAL OF GASTROENTEROLOGY